Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Anesthesiology. 2013 Dec;119(6):1474–1489. doi: 10.1097/ALN.0000000000000022

Figure 5. Activation of hypoxia-inducible factor (HIF)-dependent gene expression via prolyl hydroxylase inhibition.

Figure 5

Under hypoxic conditions (blue arrows), HIF-α and the constitutively expressed HIF-β bind and translocate into the cell nucleus. After binding to the DNA hypoxia response promoter element, the HIF heterodimer induces expression of hypoxia-sensitive genes. Under normoxic conditions (red arrows), prolyl hydroxylases (PHDs) hydroxylate HIF-α and thereby mark it for proteasomal degradation, effectively inhibiting HIF-dependent gene expression. Prevention of proteasomal HIF-α degradation using prolyl hydroxylase inhibitors, e.g., FG-2216,144 activates hypoxia-activated signaling pathways even under normoxic conditions.